Giuseppe Orefice - Publications

Bone mineral density assessment in patients with cystinuria.

Journal: Journal of nephrology

Published: January 11, 2024

Renal Cystinuria and Immune Cells (T Lymphocytes) Dysfunction: What We Know about?

Journal: Nephron

Published: August 18, 2023

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions.

Journal: eLife

Published: March 13, 2020

The HLA-DRB1 risk alleles for multiple sclerosis are differentially expressed in blood cells of patients from Southern Italy.

Journal: International journal of immunogenetics

Published: February 08, 2019

Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction.

Journal: Brain and language

Published: February 25, 2018

Aerodynamic findings and Voice Handicap Index in Parkinson's disease.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: January 31, 2018

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

Journal: Metabolism: clinical and experimental

Published: April 24, 2017

Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition.

Journal: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

Published: October 28, 2016

The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study.

Journal: Restorative neurology and neuroscience

Published: August 29, 2016

Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex®.

Journal: Acta neurologica Scandinavica

Published: July 14, 2016

Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension.

Journal: Journal of hypertension

Published: February 20, 2016

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 10, 2016